Further mechanism studies revealed that AMPK-mediated Nur77 suppression and subsequent mitochondrial function improvement played a key role in the therapeutic effects of FGF1ΔHBS on DCM (Figs. 6 and 7). Here, NR4A1 is linked to familial dilated cardiomyopathy.